H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report)’s stock price crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $22.00 and traded as high as $24.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares traded.
H. Lundbeck A/S Stock Performance
The company has a current ratio of 1.15, a quick ratio of 0.71 and a debt-to-equity ratio of 0.32. The company’s 50-day simple moving average is $22.00 and its 200-day simple moving average is $22.00. The stock has a market capitalization of $21.91 billion, a price-to-earnings ratio of 25.00 and a beta of 0.68.
H. Lundbeck A/S Company Profile
H. Lundbeck A/S (OTCMKTS:HLUYY) is a Danish pharmaceutical company headquartered in Copenhagen that specializes in the research, development and commercialization of medicines for disorders of the central nervous system. Founded in 1915 by Hans Lundbeck, the company has built a long-standing focus on neuroscience, concentrating on therapies for psychiatric and neurological conditions rather than broader therapeutic areas.
Lundbeck’s primary activities include discovery and clinical development of novel compounds, regulatory filings, manufacturing and global commercialization of prescription medicines aimed at brain health.
Read More
- Five stocks we like better than H. Lundbeck A/S
- AST SpaceMobile’s Japan Catalyst Puts Its Rollout Story Back in Focus
- Gold and Silver Recovery—3 Precious Metals Stocks for H2 2026
- Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst
- Why Kroger’s Giant Eagle Deal Could Change Everything
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.
